Christopher D.
Rare Disease Specialist at Eton Pharmaceuticals, Inc- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Mark Lalime
Chris was a direct colleague of mine for 4 years where we worked closely together. Chris is an excellent team member frequently collaborating and sharing best practices in the complex Rare Disease arena. He is great at thinking outside the box, gaining access to key KOLs, and helping a great number of patients have much improved lives. Chris has a skill set perfectly suited for the Rare Disease space always working closely with KOLs on a National and local level and a number of Advocacy Groups with the focus always centered around the patient!
Paul Stickler
I have worked with Chris for several years and he was a top performer the entire time we worked together. He was exceptionally good at building new business and maintaining existing business. Chris is an eager learner and he excels at the application of new concepts and or materials. I thoroughly enjoyed working with Chris and I fully endorse his candidacy for any rare disease or specialty pharmaceutical product. Paul Stickler
Mark Lalime
Chris was a direct colleague of mine for 4 years where we worked closely together. Chris is an excellent team member frequently collaborating and sharing best practices in the complex Rare Disease arena. He is great at thinking outside the box, gaining access to key KOLs, and helping a great number of patients have much improved lives. Chris has a skill set perfectly suited for the Rare Disease space always working closely with KOLs on a National and local level and a number of Advocacy Groups with the focus always centered around the patient!
Paul Stickler
I have worked with Chris for several years and he was a top performer the entire time we worked together. He was exceptionally good at building new business and maintaining existing business. Chris is an eager learner and he excels at the application of new concepts and or materials. I thoroughly enjoyed working with Chris and I fully endorse his candidacy for any rare disease or specialty pharmaceutical product. Paul Stickler
Mark Lalime
Chris was a direct colleague of mine for 4 years where we worked closely together. Chris is an excellent team member frequently collaborating and sharing best practices in the complex Rare Disease arena. He is great at thinking outside the box, gaining access to key KOLs, and helping a great number of patients have much improved lives. Chris has a skill set perfectly suited for the Rare Disease space always working closely with KOLs on a National and local level and a number of Advocacy Groups with the focus always centered around the patient!
Paul Stickler
I have worked with Chris for several years and he was a top performer the entire time we worked together. He was exceptionally good at building new business and maintaining existing business. Chris is an eager learner and he excels at the application of new concepts and or materials. I thoroughly enjoyed working with Chris and I fully endorse his candidacy for any rare disease or specialty pharmaceutical product. Paul Stickler
Mark Lalime
Chris was a direct colleague of mine for 4 years where we worked closely together. Chris is an excellent team member frequently collaborating and sharing best practices in the complex Rare Disease arena. He is great at thinking outside the box, gaining access to key KOLs, and helping a great number of patients have much improved lives. Chris has a skill set perfectly suited for the Rare Disease space always working closely with KOLs on a National and local level and a number of Advocacy Groups with the focus always centered around the patient!
Paul Stickler
I have worked with Chris for several years and he was a top performer the entire time we worked together. He was exceptionally good at building new business and maintaining existing business. Chris is an eager learner and he excels at the application of new concepts and or materials. I thoroughly enjoyed working with Chris and I fully endorse his candidacy for any rare disease or specialty pharmaceutical product. Paul Stickler
Credentials
-
Business Analysis: Essential Tools and Techniques
LinkedInSep, 2022- Sep, 2024 -
Listen to Lead
LinkedInSep, 2022- Sep, 2024 -
Advanced Persuasive Selling: Persuading Different Personality Types
LinkedInAug, 2022- Sep, 2024 -
Working with Your Personal Strengths and Weaknesses
LinkedInAug, 2022- Sep, 2024 -
Articulating Your Value
LinkedInDec, 2021- Sep, 2024 -
Characteristics of a Great Scrum Master
LinkedInDec, 2021- Sep, 2024 -
The Step-by-Step Guide to Building your Thought Leadership on LinkedIn
LinkedInDec, 2021- Sep, 2024 -
What Is Scrum?
LinkedInDec, 2021- Sep, 2024 -
Building Your Visibility as a Leader
LinkedInNov, 2021- Sep, 2024 -
MD Mindset, Advanced Clinical Sales, CSL Behring
CSL BehringAug, 2010- Sep, 2024 -
Communispond- Executive Presentation Skills
CommunispondJun, 2013- Sep, 2024 -
Operating Room Protocol Training
LeitersJun, 2015- Sep, 2024 -
Advanced Sales Training/The Unfair Advantage: Sell with NLP (Neurolinguistic)
Duane Lakin, PhD, Lakin AssociatesMay, 2008- Sep, 2024 -
Aseptic Techniques Training
CSLJan, 2012- Sep, 2024 -
National Patient Safety Goals Training
CSL BehringJan, 2007- Sep, 2024 -
HIPPA Training and Certification: 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022
CSLMay, 2005- Sep, 2024
Experience
-
Eton Pharmaceuticals, Inc
-
United States
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Rare Disease Specialist
-
Apr 2022 - Present
Call points include Hospitals, Academic Centers across the Central and Southeastern US. Call points include Hospitals, Academic Centers across the Central and Southeastern US.
-
-
-
Rare Disease Data Trust (RDDT)
-
United States
-
Hospitals and Health Care
-
1 - 100 Employee
-
Rare Disease Data Liaison
-
Jun 2021 - Apr 2022
Promoted compliant targeted searches for lost rare and ultra rare disease patients, against the best data (live EHR records) sponsored by commercial, directed by medical experts, in collaboration with community based health systems, for the benefit of the rare disease patient. Promoted compliant targeted searches for lost rare and ultra rare disease patients, against the best data (live EHR records) sponsored by commercial, directed by medical experts, in collaboration with community based health systems, for the benefit of the rare disease patient.
-
-
-
-
Central Region Rare Disease Sales Specialist,
-
Dec 2016 - Mar 2021
Promoted drugs for the treatment of rare and ultra-rare diseases. Promoted drugs for the treatment of rare and ultra-rare diseases.
-
-
-
-
Regional Business Manager
-
Sep 2015 - Oct 2016
Promoted generic sterile injectables and medications used during eye surgery. Promoted generic sterile injectables and medications used during eye surgery.
-
-
-
CSL Behring
-
United States
-
Biotechnology Research
-
700 & Above Employee
-
CSL Behring Area Sales Manager
-
Oct 2006 - Sep 2013
Immunology Sales - Promotion and follow through for infused immunologic therapies for the treatment of rare diseases. Immunology Sales - Promotion and follow through for infused immunologic therapies for the treatment of rare diseases.
-
-
Education
-
University of Oklahoma
Bachelor of Arts - BA, Advertising
Community
